Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Chegg
CHGG
$88.9M
| $525K | ﹤0.01% |
+296,833
| New | +$727K |
|
2002
CALL
Saia
SAIA
$9.32B
| $525K | ﹤0.01% |
1,200
-100
| -8% | -$42.4K |
|
2003
James River Group Holdings
JRVR
$190M
| $525K | ﹤0.01% |
83,669
-62,244
| -43% | -$457K |
|
2004
PUT
Linde
LIN
$226B
| $525K | ﹤0.01% |
1,100
-4,500
| -80% | -$2.05M |
|
2005
PUT
Polaris
PII
$3.66B
| $524K | ﹤0.01% |
6,300
-8,400
| -57% | -$682K |
|
2006
PUT
Lear
LEA
$8.18B
| $524K | ﹤0.01% |
+4,800
| New | +$546K |
|
2007
Garrett Motion
GTX
$4.82B
| $522K | ﹤0.01% |
+63,872
| New | +$537K |
|
2008
BRC Group Holdings
RILY
$283M
| $521K | ﹤0.01% |
+99,155
| New | +$1.1M |
|
2009
PUT
RadNet
RDNT
$5.88B
| $520K | ﹤0.01% |
+7,500
| New | +$473K |
|
2010
PUT
Synchrony
SYF
$26B
| $519K | ﹤0.01% |
10,400
+200
| +2% | +$9.68K |
|
2011
Stepan Co
SCL
$1.41B
| $518K | ﹤0.01% |
6,703
-3,211
| -32% | -$255K |
|
2012
PUT
Dover
DOV
$27.4B
| $518K | ﹤0.01% |
2,700
-2,600
| -49% | -$474K |
|
2013
CALL
Caesars Entertainment
CZR
$6.04B
| $518K | ﹤0.01% |
12,400
-5,800
| -32% | -$218K |
|
2014
PUT
Honeywell
HON
$68.1B
| $517K | ﹤0.01% |
+2,653
| New | +$515K |
|
2015
CALL
XPeng
XPEV
$10.7B
| $516K | ﹤0.01% |
+42,400
| New | +$351K |
|
2016
PUT
Nutanix
NTNX
$18B
| $515K | ﹤0.01% |
8,700
-4,000
| -31% | -$220K |
|
2017
CALL
Cinemark Holdings
CNK
$4.45B
| $512K | ﹤0.01% |
+18,400
| New | +$468K |
|
2018
CALL
Royal Bank of Canada
RY
$284B
| $511K | ﹤0.01% |
+4,100
| New | +$471K |
|
2019
CALL
Ecolab
ECL
$80.4B
| $511K | ﹤0.01% |
+2,000
| New | +$489K |
|
2020
CALL
GXO Logistics
GXO
$5.39B
| $510K | ﹤0.01% |
+9,800
| New | +$497K |
|
2021
Vir Biotechnology
VIR
$1.68B
| $510K | ﹤0.01% |
68,113
+209
| +0.3% | +$1.81K |
|
2022
CALL
InterDigital
IDCC
$8.8B
| $510K | ﹤0.01% |
+3,600
| New | +$472K |
|
2023
Intellia Therapeutics
NTLA
$1.76B
| $510K | ﹤0.01% |
24,803
-36,980
| -60% | -$853K |
|
2024
PUT
Chord Energy
CHRD
$7.91B
| $508K | ﹤0.01% |
+3,900
| New | +$598K |
|
2025
PUT
Warner Bros
WBD
$72B
| $507K | ﹤0.01% |
+61,400
| New | +$480K |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.